Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
Co-Diagnostics Inc. (CODX), a molecular diagnostics company focused on infectious disease testing solutions, is trading at $1.42 as of mid-April 2026, marking a 2.90% gain in recent sessions. No recent earnings data is available for the stock as of this analysis, so this breakdown focuses primarily on prevailing market context, key technical levels, and potential short-term price scenarios for CODX. The stock has traded in a relatively tight range over the past several weeks, with price action l
Co-Diag (CODX) Stock Resistance Rejection (Bullish Sentiment) 2026-04-15 - Swing Trade
CODX - Stock Analysis
3672 Comments
1224 Likes
1
Davinee
Experienced Member
2 hours ago
The article provides actionable insights without overcomplicating the subject.
π 223
Reply
2
Misael
Daily Reader
5 hours ago
A clear and practical breakdown of market movements.
π 59
Reply
3
Gather
Registered User
1 day ago
Who else is on the same wavelength?
π 86
Reply
4
Mayar
Senior Contributor
1 day ago
Volatility indicators suggest caution in the near term.
π 121
Reply
5
Eskil
Loyal User
2 days ago
That deserves an epic soundtrack. πΆ
π 158
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.